Effect of structural modification of α-aminoxy peptides on their intestinal absorption and transport mechanism

Molecular Pharmaceutics

Volumn 8, Issue 4, 2011, Pages 1073-1082

  Ma, Bin ^a   Zha, Huiyan ^b   Li, Na ^a   Yang, Dan ^b   Lin, Ge ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA AMINOXY PEPTIDE; BREAST CANCER RESISTANCE PROTEIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PEPTIDOMIMETIC AGENT; PROPIONIC ACID; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RAT; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CACO-2 CELLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INTESTINAL ABSORPTION; MALE; MASS SPECTROMETRY; P-GLYCOPROTEINS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 79961056417     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp1003866     Document Type: Article

References (39)

1. Goodman, C. M.; Choi, S.; Shandler, S.; DeGrado, W. F. Foldamers as versatile frameworks for the design and evolution of function Nat. Chem. Biol. 2007, 3, 252-262 (Pubitemid 46628637)
2. Hill, D. J.; Mio, M. J.; Prince, R. B.; Hughes, T. S.; Moore, J. S. A field guide to foldamers Chem. Rev. 2001, 101, 3893-4012
3. Li, X.; Wu, Y. D.; Yang, D. Alpha-aminoxy acids: new possibilities from foldamers to anion receptors and channels Acc. Chem. Res. 2008, 41, 1428-1438
4. Wu, Y. D.; Wang, D. P.; Chan, K. W. K.; Yang, D. Theoretical study of peptides formed by aminoxy acids J. Am. Chem. Soc. 1999, 121, 11189-11196 (Pubitemid 129541254)
5. Frackenpohl, J.; Arvidsson, P. I.; Schreiber, J. V.; Seebach, D. The outstanding biological stability of beta- and gamma-peptides toward proteolytic enzymes: an in vitro investigation with fifteen peptidases ChemBioChem 2001, 2, 445-455 (Pubitemid 33723576)
6. Li, X.; Yang, D. Peptides of aminoxy acids as foldamers Chem. Commun. (Cambridge) 2006, 28, 3367-3379 (Pubitemid 44200344)
7. Li, X.; Shen, B.; Yao, X. Q.; Yang, D. A Small synthetic molecule forms chloride channels to mediate chloride transport across cell membranes J. Am. Chem. Soc. 2007, 129, 7264-7265 (Pubitemid 46980799)
8. Yang, D.; Li, X.; Sha, Y.; Wu, Y. D. A cyclic hexapeptide comprising alternating alpha-aminoxy and alpha-amino acids is a selective chloride ion receptor Chemistry 2005, 11, 3005-3009 (Pubitemid 40672457)
9. Yang, D.; Qu, J.; Li, W.; Zhang, Y. H.; Ren, Y.; Wang, D. P.; Wu, Y. D. Cyclic hexapeptide of D,L-alpha-aminoxy acids as a selective receptor for chloride ion J. Am. Chem. Soc. 2002, 124, 12410-12411 (Pubitemid 35204556)
10. Zhang, L.; Zheng, Y.; Chow, M. S.; Zuo, Z. Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model Int. J. Pharm. 2004, 287, 1-12 (Pubitemid 39487237)
11. Artursson, P. Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells J. Pharm. Sci. 1990, 79, 476-482 (Pubitemid 20221389)
12. Asano, T.; Ishihara, K.; Morota, T.; Takeda, S.; Aburada, M. Permeability of the flavonoids liquiritigenin and its glycosides in licorice roots and davidigenin, a hydrogenated metabolite of liquiritigenin, using human intestinal cell line Caco-2 J. Ethnopharmacol. 2003, 89, 285-289 (Pubitemid 37378204)
13. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells Biochem. Biophys. Res. Commun. 1991, 175, 880-885
14. Sun, H.; Zhang, L.; Chow, E. C.; Lin, G.; Zuo, Z.; Pang, K. S. A catenary model to study transport and conjugation of baicalein, a bioactive flavonoid, in the Caco-2 cell monolayer: demonstration of substrate inhibition J Pharmacol Exp Ther. 2008, 326, 117-126 (Pubitemid 351872137)
15. Okudaira, N.; Tatebayashi, T.; Speirs, G. C.; Komiya, I.; Sugiyama, Y. A study of the intestinal absorption of an ester-type prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug J. Pharmacol. Exp. Ther. 2000, 294, 580-587 (Pubitemid 30490832)
16. Cummins, C. L.; Salphati, L.; Reid, M. J.; Benet, L. Z. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model J. Pharmacol. Exp. Ther. 2003, 305, 306-314 (Pubitemid 36373865)
17. Zhang, L.; Lin, G.; Chang, Q.; Zuo, Z. Role of intestinal first-pass metabolism of baicalein in its absorption process Pharm. Res. 2005, 22, 1050-1058 (Pubitemid 41127062)
18. Cook, T. J.; Shenoy, S. S. Intestinal permeability of chlorpyrifos using the single-pass intestinal perfusion method in the rat Toxicology 2003, 184, 125-133 (Pubitemid 36009294)
19. Yee, S. In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man - fact or myth Pharm. Res. 1997, 14, 763-766 (Pubitemid 27281671)
20. Zhang, L.; Lin, G.; Kovacs, B.; Jani, M.; Krajcsi, P.; Zuo, Z. Mechanistic study on the intestinal absorption and disposition of baicalein Eur. J. Pharm. Sci. 2007, 31, 221-231 (Pubitemid 46818982)
21. Zhang, Z. Y.; Wong, Y. N. Enzyme kinetics for clinically relevant CYP inhibition Curr. Drug Metab. 2005, 6, 241-257 (Pubitemid 40753855)
22. Ambudkar, S. V.; Dey, S.; Hrycyna, C. A.; Ramachandra, M.; Pastan, I.; Gottesman, M. M. Biochemical, cellular, and pharmacological aspects of the multidrug transporter Annu. Rev. Pharmacol. Toxicol. 1999, 39, 361-398 (Pubitemid 29222564)
23. Zhang, L.; Zhang, Y. D.; Strong, J. M.; Reynolds, K. S.; Huang, S. M. A regulatory viewpoint on transporter-based drug interactions Xenobiotica 2008, 38, 709-724
24. Constantinides, P. P.; Wasan, K. M. Lipid formulation strategies for enhancing intestinal transport and absorption of P-glycoprotein (P-gp) substrate drugs: in vitro/in vivo case studies J. Pharm. Sci. 2007, 96, 235-248 (Pubitemid 46363554)
25. MacLean, C.; Moenning, U.; Reichel, A.; Fricker, G. Closing the gaps: a full scan of the intestinal expression of p-glycoprotein, breast cancer resistance protein, and multidrug resistance-associated protein 2 in male and female rats Drug Metab. Pharmacokinet. 2008, 36, 1249-1254 (Pubitemid 351929307)
26. Bock-Hennig, B. S.; Kohle, C.; Nill, K.; Bock, K. W. Influence of t-butylhydroquinone and beta-naphthoflavone on formation and transport of 4-methylumbelliferone glucuronide in Caco-2/TC-7 cell monolayers Biochem. Pharmacol. 2002, 63, 123-128 (Pubitemid 34158811)
27. Prime-Chapman, H. M.; Fearn, R. A.; Cooper, A. E.; Moore, V.; Hirst, B. H. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells J. Pharmacol. Exp. Ther. 2004, 311, 476-484 (Pubitemid 39391531)
28. Berger, V.; Gabriel, A. F.; Sergent, T.; Trouet, A.; Larondelle, Y.; Schneider, Y. J. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2) Toxicol. Lett. 2003, 140-141, 465-476 (Pubitemid 36378966)
29. Schrickx, J.; Lektarau, Y.; Fink-Gremmels, J. Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cells Arch. Toxicol. 2006, 80, 243-249
30. Artursson, P.; Magnusson, C. Epithelial transport of drugs in cell culture. II: Effect of extracellular calcium concentration on the paracellular transport of drugs of different lipophilicities across monolayers of intestinal epithelial (Caco-2) cells J. Pharm. Sci. 1990, 79, 595-600 (Pubitemid 20222724)
31. McMillan, J. M.; Walle, U. K.; Walle, T. S-adenosyl-L-methionine: transcellular transport and uptake by Caco-2 cells and hepatocytes J. Pharm. Pharmacol. 2005, 57, 599-605 (Pubitemid 40562399)
32. Stetinova, V.; Smetanova, L.; Kholova, D.; Svoboda, Z.; Kvetina, J. Transepithelial transport of ambroxol hydrochloride across human intestinal Caco-2 cell monolayers Gen. Physiol. Biophys. 2009, 28, 309-315
33. Dorkoosh, F. A.; Broekhuizen, C. A.; Borchard, G.; Rafiee-Tehrani, M.; Verhoef, J. C.; Junginger, H. E. Transport of octreotide and evaluation of mechanism of opening the paracellular tight junctions using superporous hydrogel polymers in Caco-2 cell monolayers J. Pharm. Sci. 2004, 93, 743-752 (Pubitemid 38332306)
34. Hilgendorf, C.; Ahlin, G.; Seithel, A.; Artursson, P.; Ungell, A. L.; Karlsson, J. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines Drug Metab. Dispos. 2007, 35, 1333-1340 (Pubitemid 47121774)
35. Lee, Y. H.; Sinko, P. J. Oral delivery of salmon calcitonin Adv. Drug Delivery Rev. 2000, 42, 225-238 (Pubitemid 30645779)
36. Raub, T. J. P-glycoprotein recognition of substrates and circumvention through rational drug design Mol. Pharmaceutics 2006, 3, 3-25 (Pubitemid 43331747)
37. Giacomini, K. M.; Huang, S. M.; Tweedie, D. J.; Benet, L. Z.; Brouwer, K. L.; Chu, X.; Dahlin, A.; Evers, R.; Fischer, V.; Hillgren, K. M.; Hoffmaster, K. A.; Ishikawa, T.; Keppler, D.; Kim, R. B.; Lee, C. A.; Niemi, M.; Polli, J. W.; Sugiyama, Y.; Swaan, P. W.; Ware, J. A.; Wright, S. H.; Yee, S. W.; Zamek-Gliszczynski, M. J.; Zhang, L. Membrane transporters in drug development Nat. Rev. Drug Discovery 2010, 9, 215-236
38. Klaassen, C. D.; Aleksunes, L. M. Xenobiotic, bile acid, and cholesterol transporters: function and regulation Pharmacol. Rev. 2010, 62, 1-96
39. Honda, Y.; Ushigome, F.; Koyabu, N.; Morimoto, S.; Shoyama, Y.; Uchiumi, T.; Kuwano, M.; Ohtani, H.; Sawada, Y. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux Br. J. Pharmacol. 2004, 143, 856-864 (Pubitemid 39664844)